Palisade Bio, Inc. Profile Avatar - Palmy Investing

Palisade Bio, Inc.

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract…

Biotechnology
US, Carlsbad [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Palisade Bio, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Palisade Bio, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Palisade Bio, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of PALI's Analysis
CIK: 1357459 CUSIP: 696389105 ISIN: US6963892046 LEI: - UEI: -
Secondary Listings
PALI has no secondary listings inside our databases.